Hair Million promotes hair growth in both women and men. It is made of healthy and safe herbs that have been well documented and in use for thousands of years, especially in Asia. Although these herbs have not yet been scientifically proven by placebo-controlled clinical trials nor the ingedients of the herbs charaterized in laboratory, the herbal formula has been proven efficacious anecdotally in a number of people who experience hair thinning and hair loss. There are other herbs and nutritions that also work in anecdotal cases. For instance, Saw palmetto fruit extract have beens shown effective. Other herbs, such as sage, evening primrose, horse chestnut, horsetail, rosemary have been suggested. B vitamins, especially biotin might help as well.

Hair Million is a finest product that would ward off hair loss and promote hair growth, without side effect. Hair Million should be orally taken as suggested for a few months to see the positive effects: stopping hair thinning, and hair loss, and observing new hair growth. For some individuals, none of the hair growth products or methods would work, and the reasons are not always clear. People with alopecia areata would certainly benefit from Hair Million. Once you know it works for you, you could take it for months and years. It often results in complete restoration of hair.



  • Baldness: Does appearance matter?
  • Hair loss during treatment with oral contraceptives
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • Postmenopausal frontal fibrosing alopecia.
  • Depression circumstantially related to the administration of finasteride for androgenetic alopecia.
  • Baldness: Does appearance matter?
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Does the recipient site influence the hair growth characteristics in hair transplantation?
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Treatment of hyperandrogenic alopecia in women.
  • Frictional hair loss in Iraqi patients.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia.
  • Effect of two consecutive earthquakes on outbreaks of alopecia areata.
  • The potential role of minoxidil in the hair transplantation setting.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Treatment of hyperandrogenic alopecia in women.
  • Treatment of hyperandrogenic alopecia in women.
  • The hair follicle as a target for gene therapy
  • Idiopathic CD4+ T lymphocytopenia associated with disseminated flat warts and alopecia areata.
  • Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
  • Postmenopausal frontal fibrosing alopecia.
  • Androgenetic alopecia
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • Postmenopausal frontal fibrosing alopecia.
  • Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • Nutritional factors and hair loss.
  • Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
  • Alopecia areata: update on therapy
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Approach to the adult female patient with diffuse nonscarring alopecia.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Male androgenetic alopecia.
  • The art of repair in surgical hair restoration--part II: the tactics of repair.
  • Postmenopausal frontal fibrosing alopecia.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • The hydraulic influence in androgen-related hair growth: implications in autoimmune disease.
  • Hair loss in women with hyperandrogenism: four cases responding to finasteride.
  • The potential role of minoxidil in the hair transplantation setting.
  • Does the recipient site influence the hair growth characteristics in hair transplantation?
  • Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
  • Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
  • Postmenopausal frontal fibrosing alopecia.
  • Mouse models for human hair loss disorders.
  • Effect of two consecutive earthquakes on outbreaks of alopecia areata.
  • Female pattern hair loss.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • Treatment of hyperandrogenic alopecia in women.
  • The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.
  • The potential role of minoxidil in the hair transplantation setting.
  • Female pattern hair loss.
  • Postmenopausal frontal fibrosing alopecia.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Treatment of alopecia areata with diphencyprone
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • Idiopathic CD4+ T lymphocytopenia associated with disseminated flat warts and alopecia areata.
  • A philosophy and strategy for surgical hair restoration: a 10-year experience.
  • Mouse models for human hair loss disorders.
  • Loose anagen syndrome as a severity factor for trichotillomania.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Androgens and alopecia.
  • Curly bare (cub), a new mouse mutation on chromosome 11 causing skin and hair abnormalities, and a modifier gene (mcub) on chromosome 5.
  • Effect of two consecutive earthquakes on outbreaks of alopecia areata.
  • Hair loss in women with hyperandrogenism: four cases responding to finasteride.
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • Follicular unit extraction: minimally invasive surgery for hair transplantation.



    Hair loss and hair growth online references:

    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |